Blog Archives - Page 3 of 10 - Bodhi Addiction Treatment & Wellness

Waiting for a Bed: How to Stay Safer in the Days Before Residential Treatment Starts

A group of people gathered around a table — supporting a loved one during the first weeks of residential rehab

Almost nobody walks into residential treatment the same hour they decide to go. There is a phone call, an insurance check, a bed date — and then a gap. Sometimes it is eighteen hours. Sometimes it is four days. That gap is the most dangerous stretch of the whole process, and it is the part almost no one prepares for.

People who work in Northern California residential programs see the same pattern constantly: someone makes the hardest decision of their life on a Tuesday, gets an admission date for Friday, and then has to survive Wednesday and Thursday with no structure, a lot of shame, and a body that is already asking for more. What happens in those two days determines whether the person arrives at all.

What the Wait Actually Feels Like

The relief of having decided is real, and it is short. Within a few hours it is usually replaced by something closer to dread. People describe a strange, floating quality to the days before admission — work has been handled or abandoned, the secret is out, and there is nothing left to do but wait. Old routines are gone but nothing has replaced them.

That vacuum is where two specific thoughts show up. The first is one last time — a farewell tour framed as closure, which is very often the heaviest use of the entire year and the reason some admissions become emergency room visits instead. The second is the opposite and just as risky: I should show up clean. Both are attempts to manage an unbearable few days. Neither is safe.

If Alcohol or Benzodiazepines Are Involved, This Is a Medical Situation

This is the part to read twice. Withdrawal from alcohol and from benzodiazepines such as Xanax, Ativan, Klonopin, or Valium is not merely uncomfortable — it carries a genuine risk of seizures and, in severe cases, delirium tremens, which can be fatal. These are among the few substances where stopping abruptly without medical supervision is more dangerous than continuing until care is available.

So if a person has been drinking heavily every day, or has been taking benzodiazepines regularly, the correct advice before admission is not to white-knuckle it into sobriety over the weekend. It is to call the program and say exactly what is being used, how much, and when it was last taken. Admissions staff handle that conversation many times a week and will either move the date up or tell you what to do in the meantime. Withdrawal from these substances needs to be medically managed, full stop. The number is (877) 328-1968.

Warning signs that the wait has become an emergency: shaking that will not settle, a racing heart, vomiting that prevents keeping fluids down, confusion about time or place, seeing or hearing things that are not there, or any seizure activity. Those mean an emergency room now, not a phone call to the program later. The National Institute on Alcohol Abuse and Alcoholism maintains plain-language material on the severity of alcohol withdrawal at niaaa.nih.gov.

If Opioids Are Involved, Plan Around the Supply, Not the Substance

Opioid withdrawal is miserable but rarely dangerous on its own. The danger during a pre-admission wait is different: reduced tolerance combined with an unpredictable illicit supply. Someone who cuts back for two days and then uses their usual amount is taking a far larger risk than they realize, and the National Institute on Drug Abuse has documented at length how thoroughly fentanyl has permeated the illicit drug supply — including in pills and powders sold as something else. Background on this is available at nida.nih.gov.

Practical steps for those days, without moralizing about them: have naloxone in the house and make sure someone besides the person who uses knows where it is and how to use it. Do not use alone behind a locked door. Assume tolerance has dropped after any break. The Centers for Disease Control and Prevention publishes overdose prevention guidance at cdc.gov, and SAMHSA operates a free, confidential national helpline for people who need support before a bed opens.

What Families Can Usefully Do

Families often spend the waiting period doing the two things that help least: interrogating and surveilling. Both raise the temperature at the exact moment the person is least able to tolerate it, and both tend to produce the disappearance they were meant to prevent.

What helps is duller and more effective. Stay physically present without commentary — sit in the same room, drive somewhere, go get food. Take over the logistics that are generating panic: the boss who needs an answer, the dog, the rent, the car in the shop. Keep the days short and structured, because unstructured time is when the plan falls apart. And say the admission date out loud, calmly, more than once.

It is also reasonable for families to prepare for the possibility that the person will change their mind, sometimes more than once, in the space of forty-eight hours. Ambivalence is a feature of substance use disorders, not evidence of dishonesty. A person can mean it completely at nine in the morning and be looking for a reason to cancel by dinner. Treating that swing as a betrayal usually ends the process; treating it as expected usually does not. Our addiction treatment team talks families through this gap regularly.

Clear the Practical Obstacles Before the Day

Every admissions team can name the same handful of last-minute cancellations: the insurance question nobody asked, the childcare that fell through, the court date two weeks out, the job that was never actually notified. None of these are unsolvable. All of them are terrible to discover at eight in the morning on admission day, when resolve is thinnest and any obstacle will do.

Sort out coverage in advance rather than assuming — you can verify insurance before the date arrives. Write down who is driving and when. Pack the night before, not the morning of. Identify the one person who will handle phone calls from work or family during the first week. If there is a pet, a child, a court obligation, or a landlord, name who is covering it in writing. A plan that lives only in someone’s head does not survive a bad morning.

What the First Days Inside Are Actually For

It can help to know what is on the other side of the wait, because the imagined version is usually worse than the real one. The early part of a residential treatment stay is mostly medical and practical: monitoring, sleep, food, vital signs, and a clinical assessment that sorts out what is withdrawal, what is a co-occurring mental health condition, and what is exhaustion. Nobody is asked to deliver a life story on day one.

The American Society of Addiction Medicine publishes the criteria most programs use to decide who needs medically managed withdrawal versus a lower level of care; an overview is available at asam.org. Knowing that level of care is a clinical determination — not a judgment about willpower — takes some of the shame out of the wait.

If the Wait Is Too Long, Say So

A person who is ready today and cannot be seen for five days is in a different situation than one waiting overnight. That is worth naming directly rather than hoping it holds. Admission dates move, bridge options exist, and outpatient or interim support can sometimes fill the gap. The wrong move is silence — disappearing from the program for four days and hoping motivation survives on its own. Call, describe the situation honestly, and ask what can be done sooner: (877) 328-1968.

The days before treatment are not a test of sincerity. They are a logistics problem with a medical component, and they are much easier to survive with a plan, a phone number, and somebody in the room.

This article is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment. Withdrawal from alcohol and benzodiazepines can be life-threatening and should always be medically supervised. If you or someone you know is experiencing a medical emergency, call 911 or go to the nearest emergency room.

September 14, 2026/by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i

Telling Your Children You Are Going to Residential Treatment: What to Say at Each Age

Blog, Family Support, Treatment Resources

how to tell your employer you're going to residential addiction treatment private conversation

Parents entering residential addiction treatment almost always ask the same question at intake, and they usually ask it last, after insurance and packing lists and work leave are settled: what do I tell my kids? The fear underneath it is that the truth will damage them. In clinical practice, the opposite is closer to reality. Children are rarely harmed by an age-appropriate, honest explanation. They are harmed by silence, by sudden disappearances, and by being left to invent an explanation on their own — one that usually casts them as the cause.

This is a guide to that conversation: what children actually need to hear, how the wording changes by age, and what to do when the answer is genuinely uncertain.

Your Children Already Know Something Has Been Wrong

Families consistently overestimate how well the situation has been hidden. Children may not have a word for substance use disorder, but they have been tracking the household for a long time. They know which nights are unpredictable. They know the difference between the two versions of a parent’s voice. Younger children often show it behaviorally rather than verbally — clinginess at bedtime, stomachaches before school, sudden perfectionism. Older children tend to show it by managing: making their own lunches, keeping their younger siblings occupied, not asking for things.

This matters because the conversation is not a revelation. It is a correction. You are replacing a confusing story your child has been carrying privately with a clearer one that has an adult in charge of it. That reframe takes a lot of pressure off the parent who is dreading the talk.

Three Things Every Child Needs to Hear

Regardless of age, three messages do most of the work. Children’s mental health guidance from bodies including the National Institute of Mental Health consistently emphasizes clear, developmentally matched explanations over protective vagueness.

One: this is not your fault. Say it directly, and say it more than once. Children under about ten are developmentally prone to assuming they caused adult distress. They will not volunteer this belief; you have to name it and dismiss it for them.

Two: this is an illness, and I am getting treatment for it. Framing matters enormously here. A parent who is “sick and getting help” is a parent who is doing something responsible. A parent who is “away” or “on a work trip” is a parent whose absence has no explanation, which invites worse ones.

Three: here is who is taking care of you, and here is when you will hear from me. Concrete logistics reduce anxiety more reliably than reassurance does. Name the adult. Name the day of the week they will get a phone call. Children hold onto specifics.

What to Say at Each Age

Ages three to six. Keep it to two or three sentences and expect to repeat them for weeks. Something like: “My body and my brain are sick, so I’m going to a place where doctors help grown-ups get better. Grandma is staying here with you. I’ll call you every Sunday.” Do not explain substances. At this age the child’s real question is about safety and return, not about diagnosis.

Ages seven to eleven. Children in this range can hold a cause-and-effect explanation and will ask follow-ups. You can name the substance simply: “I’ve been drinking too much alcohol, and it changed the way my brain works so I couldn’t stop on my own. That’s what the doctors are treating.” Expect logistical and social questions — will people find out, do I have to tell my teacher, will you be there for my birthday. Answer the ones you can and say “I don’t know yet” for the rest.

Ages twelve to seventeen. Teenagers usually already know, often in more detail than parents suspect, and the dominant emotion is frequently anger rather than fear. Do not ask a teenager to be understanding. Acknowledge the specific things that went wrong — the missed game, the argument, the night they had to handle something no fifteen-year-old should handle. Vague apology reads as evasion at this age; specific acknowledgment reads as real. Also be direct that family risk is heritable and that this is a reason for them to be careful, not a verdict on their future. The National Institute on Drug Abuse describes substance use disorder as a treatable condition shaped by both genetic and environmental factors, which is a useful and honest frame for an adolescent who is quietly wondering whether they are next.

Adult children. Do not assume they need less. Adult children often carry the longest history and the most unresolved resentment, and they are also the ones most likely to be recruited into caretaking during your absence. Be explicit about what you are and are not asking them to take on.

Questions Children Ask, and Answers That Hold Up

“Are you going to die?” Answer the medical question honestly and without elaboration: “No. That’s part of why I’m going now, before it gets worse.”

“Can I come see you?” Many residential programs, including ours, schedule family sessions and supervised visits once a person is medically stable. Give a realistic timeframe rather than an immediate yes.

“Will you do it again?” This is the hardest one, and the honest answer is not a promise. “I can’t promise you a feeling. I can promise you that I’m doing the work and that you will hear the truth from me” respects the child’s intelligence. Children who have been promised before can tell the difference.

Do Not Delay Admission to Find a Better Moment

Parents routinely try to time treatment around the school calendar, a holiday, or a custody arrangement. Some scheduling flexibility is reasonable. Waiting weeks is often not, and with certain substances it is medically dangerous.

Withdrawal from alcohol and from benzodiazepines such as Xanax, Ativan, or Klonopin can produce seizures, delirium, and in severe cases death. Neither should be stopped abruptly or tapered without medical supervision, and both require a medically managed detox rather than a decision to white-knuckle it at home until the semester ends. Guidance from the National Institute on Alcohol Abuse and Alcoholism and the Substance Abuse and Mental Health Services Administration is consistent on the need for clinical monitoring during this period. If you are drinking daily or taking benzodiazepines regularly, the safest sequence is to get assessed first and plan the conversation with your children second. Call us at 877-328-1968 and we can help you sort out which parts of the timeline are actually movable.

Staying Connected During Your Stay

Contact schedules vary by program and by clinical stage. The first several days of residential treatment are typically protected, partly because early withdrawal is physically rough and partly because emotionally loaded phone calls in week one tend to destabilize rather than reassure. Once calls begin, a predictable rhythm — same day, same time — does more for a child than frequent unscheduled contact.

Two practical suggestions from family work. First, write letters even to children too young to read them; a caregiver reading a parent’s words aloud is a powerful continuity ritual. Second, brief the caregiving adult on what the child was told, word for word, so the story stays consistent across households. Inconsistent accounts are what children notice and worry at.

What Comes After

Reunification is rarely the scene parents picture. Children frequently test for a while — regression in younger kids, cool distance in teenagers — and that testing is a normal check on whether the change is real. It usually resolves over months, not days, through repetition rather than conversation.

Family therapy is where most of this gets processed, and co-occurring conditions such as depression, anxiety, or trauma often need attention alongside the substance use for the household to actually stabilize; integrated mental health treatment is part of the same plan, not a separate one. If you are earlier in the process and still deciding, a confidential consultation is a reasonable first step, or call 877-328-1968 to talk it through with a clinician.

One last thing worth saying plainly: going to treatment is not something to apologize to your children for. It is the most direct evidence they have that the pattern they have been living with is being taken seriously.

This article is for educational purposes only and is not a substitute for individualized medical or clinical advice. Withdrawal from alcohol and benzodiazepines can be life-threatening and requires medical supervision. If you or someone else is experiencing a medical emergency, call 911. For free, confidential, 24/7 support, the SAMHSA National Helpline is available at 1-800-662-4357.

September 11, 2026/by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i

Post-Acute Withdrawal Syndrome: What Months Two and Three Really Feel Like

Addiction, Blog, Treatment Resources

Peaceful natural setting representing mindfulness practice in addiction recovery

Most people preparing for detox brace for the first week. They picture the shaking, the sweating, the sleepless nights, and they tell themselves that if they can just get through it, the hard part will be behind them. Then week one ends, the acute symptoms fade, and somewhere around the fifth or sixth week something strange happens: the fog rolls back in. Sleep breaks apart again. Motivation disappears. A person who felt clear-headed on day twenty wakes up on day forty convinced they are getting worse.

That stretch has a name in clinical settings: post-acute withdrawal, sometimes called PAWS. It is one of the least understood parts of early recovery and one of the most common reasons people conclude that treatment did not work, when in fact their nervous system is still recalibrating.

What People Mean by Post-Acute Withdrawal

Post-acute withdrawal refers to the cluster of mood, sleep, cognitive, and stress-response symptoms that can linger after acute physical withdrawal has resolved. It is worth being precise here: PAWS is a descriptive clinical term rather than a formal diagnosis in the DSM-5-TR, and researchers continue to debate how best to define and measure it. Clinicians use it because it names something they observe constantly, even if the underlying mechanisms are still being mapped.

What is well established is that chronic substance use changes how the brain regulates reward, stress, and sleep, and that those systems take considerably longer to normalize than the liver takes to clear a drug. The National Institute on Drug Abuse describes addiction as a treatable but chronic condition involving lasting changes in brain circuits, which is the clearest way to understand why a person can be medically stable and still feel unwell weeks later. You can read more about how those circuits are affected through the National Institute on Drug Abuse.

Acute Withdrawal Versus the Long Tail

Acute withdrawal is the body clearing a substance and reacting to its absence. It is time-limited, it is physically measurable, and with some substances it is dangerous.

This distinction matters for safety. Withdrawal from alcohol and from benzodiazepines such as alprazolam, clonazepam, or diazepam can produce seizures, delirium, and autonomic instability, and both can be fatal without medical management. Nobody should attempt to stop either one abruptly on their own. A medically supervised detox with appropriate monitoring and, where indicated, a structured taper is not a comfort measure; it is a safety requirement. If alcohol or benzodiazepines are part of the picture, the first call should be to a medical provider or to an admissions clinician at (877) 328-1968 before anything else is decided.

Post-acute withdrawal is different in character. It is rarely dangerous in itself. What makes it risky is what people do in response to it, because a person who believes recovery has failed is a person at elevated risk of returning to use, sometimes with a tolerance that no longer protects them.

What It Actually Feels Like Around Week Six

In residential care, the reports are remarkably consistent. People describe:

Sleep that fragments again. Falling asleep is manageable, but they wake at 3 a.m. and cannot get back down. Dreams are unusually vivid, sometimes about using.
Flat affect. Food tastes like nothing. Music that used to matter does not land. This anhedonia is often the single most demoralizing symptom.
Cognitive stickiness. Losing the thread mid-sentence, rereading the same paragraph, struggling to hold a phone number in mind long enough to dial it.
A short fuse and a long recovery from stress. A minor scheduling change produces a disproportionate reaction, and the agitation lasts for hours rather than minutes.
Cravings that arrive without warning. Not the grinding hunger of week one, but sudden intrusive spikes, frequently triggered by something small and sensory.

The symptoms tend to come in waves rather than a steady line. Someone can have four good days and then a difficult one, and because the difficult day follows the good ones, it feels like backsliding rather than an ordinary fluctuation.

Why the Waves Come and Go

The wave pattern is one of the more useful things to teach a person early, because it reframes a bad day as weather instead of climate. Over weeks and months, the good stretches generally lengthen and the difficult stretches shorten, but the trajectory is visible only in retrospect. That is precisely why treatment programs ask people to track mood, sleep, and cravings in writing. A person on day fifty cannot feel the improvement over day thirty; a log can show it to them.

Duration varies widely and depends on the substance, how long it was used, co-occurring conditions, sleep, nutrition, and medical history. Some people notice very little. Others describe intermittent symptoms for several months. Anyone offering a precise timeline is overselling their certainty.

What Families Notice From the Outside

Families often expect steady improvement after treatment and are unsettled by what they see instead: a person who is sober but withdrawn, irritable, sleeping oddly, and not obviously happier. It is easy to read that as secret use or as a lack of effort, and that misreading damages trust at exactly the wrong moment.

The more useful stance is curiosity. Asking how sleep has been, whether the flatness is lifting at all, and what the last difficult day looked like tends to open a conversation. Demanding evidence of happiness tends to close one. Family education sessions exist largely to prepare people for this stretch, and our residential treatment program builds that education in rather than leaving families to guess.

What Helps

There is no medication that treats post-acute withdrawal as a syndrome, and claims otherwise deserve skepticism. What does appear to help, consistently and unglamorously:

Protected sleep timing. A fixed wake time, light exposure in the morning, and no caffeine after midday do more than any supplement.
Regular aerobic movement. Even a daily walk. It supports sleep architecture and mood in ways people can usually feel within a couple of weeks.
Consistent eating. Blood sugar swings mimic and amplify anxiety and irritability.
Treating co-occurring conditions properly. Depression, anxiety disorders, PTSD, and ADHD do not vanish with sobriety, and untreated symptoms are frequently mistaken for post-acute withdrawal. The National Institute of Mental Health is a reliable starting point, and integrated mental health treatment alongside substance use care is the appropriate response.
Medication for opioid or alcohol use disorder where indicated. Buprenorphine, methadone, naltrexone, and acamprosate treat the underlying disorder and can reduce craving intensity during this window.
Staying connected. Isolation makes every symptom on this list worse.

When to Escalate Care

Post-acute symptoms are normal. Some things are not, and warrant prompt clinical attention: thoughts of suicide or self-harm, depressive symptoms that are worsening rather than fluctuating, an inability to function at work or at home, or cravings that have shifted from intrusive to planning. Structured outpatient treatment often provides enough support to carry someone through, and a return to residential care is sometimes the right call rather than a failure. The SAMHSA National Helpline offers free, confidential referrals at any hour. Guidance on alcohol-specific recovery is available through the National Institute on Alcohol Abuse and Alcoholism. If someone is in immediate danger, call 988 or 911.

Where to Start

If you or someone you care about is in that difficult second or third month and wondering whether recovery is working, that question is worth asking out loud to a clinician rather than alone at 3 a.m. Our admissions team in Northern California can talk through what is happening and what level of care fits. Call (877) 328-1968.

This article is for educational purposes only and is not medical advice, a diagnosis, or a substitute for evaluation by a qualified healthcare professional. Withdrawal from alcohol and benzodiazepines can be life-threatening and requires medical supervision. If you are experiencing a medical or mental health emergency, call 911 or 988.

September 11, 2026/by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i

Chronic Pain and Opioid Use Disorder: Treating Both at the Same Time

Addiction, Blog, Prescription Drugs, Treatment Resources

IV drip on a stainless steel stand — 5-day medical detox in residential rehab

Very few people arrive at residential treatment saying “I have an opioid use disorder.” Far more often, the sentence starts somewhere else: a back injury in 2019, a shoulder surgery, an autoimmune condition, a car accident that never fully resolved. The prescription was legitimate. The pain was real. And somewhere in the years that followed, the line between treating pain and needing the medication stopped being visible from the inside.

This is one of the harder presentations in addiction medicine, because the two problems argue with each other. Treat the pain aggressively and you may feed the use disorder. Remove the opioids and you may leave someone in genuine physical distress with no plan. People in this situation are often bounced between a pain clinic that will not manage addiction and a program that will not manage pain. Both problems are treatable, at the same time, by the same team.

Why Pain and Opioid Use Disorder Get Tangled Together

Two things happen over months and years of opioid therapy that make this predictable rather than unusual. The first is tolerance: the same dose does less, so the dose climbs, and the climb feels medically justified because the pain is genuinely still there. The second is that opioid withdrawal itself hurts. Muscles ache, joints throb, the nervous system turns up its sensitivity. So a person tapering down does not experience “less medication” — they experience their original pain plus withdrawal pain, arriving together, and reasonably conclude the medication was the only thing working.

There is also a phenomenon clinicians watch for called opioid-induced hyperalgesia, in which long-term opioid exposure appears to increase sensitivity to pain rather than reduce it. How often it occurs, and how much it contributes in any individual case, is still being studied. But it is one reason some people report that their pain is more manageable several months after coming off high-dose opioids than it was while on them — a result that surprises almost everyone who experiences it. The National Institute on Drug Abuse maintains accessible overviews of how opioid tolerance and dependence develop, and it is worth reading before assuming the problem is a character issue rather than a physiological one.

What the First Week Actually Feels Like

Honesty is more useful here than reassurance. In a medically managed detox, the first three to five days off short-acting opioids are physically miserable for most people: sweating and chills alternating, restless legs, a gut that will not settle, and almost no real sleep. When chronic pain is in the picture, add the specific complaint people voice most on day two, which is that their original pain site is now screaming. A person with lumbar disc disease will say their back has never been this bad. It is not imagined and it is not permanent.

What changes the week is what the medical team does with it. Comfort medications for nausea, cramping, and autonomic symptoms. Non-opioid analgesia where it is appropriate. Position changes, heat, gentle movement rather than bed rest, and a nursing staff that treats a 3 a.m. pain report as clinical information instead of drug-seeking. By roughly day five to seven, most people describe the withdrawal layer peeling off and the underlying pain becoming a defined thing again — still there, but no longer amplified by a nervous system in crisis. That distinction, felt rather than explained, is often the first moment a person believes treatment might work.

The Fear That Keeps People Out of Treatment

The most common reason people with chronic pain delay care is not denial. It is a specific and rational fear: that a treatment program will take away the only thing that lets them function and hand them a worksheet in return. Some have already had that experience somewhere else.

A program should be able to answer that fear directly at the assessment call, before admission. What is your approach to pain? Will there be a physician involved in pain management, not just addiction treatment? What happens if my pain is worse in week two? Who coordinates with my orthopedist or rheumatologist while I am here? Anyone can ask these questions of our admissions team at (877) 328-1968. A program that cannot give concrete answers is probably not the right setting for this presentation.

Medications That Can Address Both Problems

Medication decisions belong to a prescriber who has examined the person, so what follows is orientation, not a recommendation. Buprenorphine is often central to this conversation because it treats opioid use disorder and has analgesic properties of its own, which means for some people it addresses both targets with one medication. Dosing for pain can differ from dosing for use disorder alone, and the transition has to be timed carefully against the last opioid dose.

Naltrexone is a different tool entirely — it blocks opioid effects and offers no analgesia, so pain has to be covered by other means before it makes sense. Beyond opioid-specific medications, prescribers frequently build a non-opioid regimen from options used in chronic pain care generally, including certain antidepressants and anticonvulsants that act on nerve pain, topical agents, and scheduled non-opioid analgesics. The American Society of Addiction Medicine publishes clinical practice guidance on opioid use disorder treatment that informs how programs structure these decisions.

Non-Medication Pain Care That Earns Its Place

Some of what gets offered as holistic pain management is filler; the test is whether it changes what a person can actually do. Graded movement and physical therapy address the deconditioning that years of pain-driven inactivity produce, and deconditioning is itself a pain generator. Sleep restoration matters enormously, because pain tolerance drops sharply after poor sleep and poor sleep is nearly universal in early recovery. Cognitive behavioral approaches adapted for chronic pain target the catastrophizing loop — the jump from “this hurts” to “this will never improve and my life is over” — which measurably affects how disabling pain feels.

Trauma treatment belongs on this list too. A significant share of people with long-standing pain also carry post-traumatic stress, and the two amplify each other through a shared nervous system. Programs that integrate mental health treatment with addiction care are addressing both rather than sequencing them years apart.

When Other Substances Are Also in the Picture

Chronic pain rarely travels alone. Alcohol is a very common addition, used for sleep or for the hours when the prescription has worn off, and benzodiazepines are frequently co-prescribed for muscle spasm or anxiety. This changes the medical picture in a way that cannot be improvised at home. Withdrawal from alcohol and from benzodiazepines carries a risk of seizures, and in severe cases can be life-threatening — unlike opioid withdrawal, which is agonizing but not usually dangerous on its own. Anyone drinking heavily every day, or taking a benzodiazepine regularly, needs medically supervised withdrawal with a physician-directed taper. Stopping abruptly, or tapering without supervision, is the scenario that puts people in an emergency room. SAMHSA operates a free, confidential national helpline that can direct anyone to medically supervised options in their area, and the CDC publishes public guidance on opioid prescribing and overdose prevention.

One more safety point that applies to everyone in this group: tolerance falls fast after a period without opioids, so a return to a previously normal dose carries serious overdose risk. Naloxone should be in the house, and the people around the person should know where it is and how to use it.

What Families Notice

Families here often describe years of not knowing what they were looking at. The person was in pain, so the sleeping, the irritability, and the careful attention to refill dates all had an explanation. What families report noticing in hindsight is narrowing — fewer activities, fewer people, more of the day organized around medication timing — and a defensiveness that appeared only around that one subject.

The instinct to police the pill bottle is understandable and almost never productive. What helps more is being clear about what you have observed without diagnosing it, staying connected, and being informed enough about residential treatment to answer questions when the person is finally ready to ask them.

Building a Plan That Holds After Discharge

Residential treatment stabilizes this presentation; it does not finish it. A discharge plan for someone with chronic pain has to name specifics: who prescribes going forward, what the pain regimen is and who adjusts it, what the plan is for a flare, which specialists are involved and whether they are communicating with each other, and what happens if surgery becomes necessary later. Leaving without those answers means solving a medical problem alone under pressure, which is the circumstance that started this.

If you are weighing residential care for yourself or someone in your family, our team can talk through the clinical picture, coverage, and whether this level of care fits — call (877) 328-1968 or check your benefits through our insurance verification page.

This article is for educational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. Decisions about opioid medications, tapering, and pain management should be made with a qualified clinician who knows your history. If you are experiencing a medical emergency, or you suspect an overdose, call 911.

September 10, 2026/by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i

The Urge to Leave Treatment Early: Why Day Six Is Harder Than Day One

Addiction, Blog, Treatment Resources

How to prepare emotionally for residential addiction treatment before admission - quiet redwood forest path

Almost nobody walks into residential treatment and stays comfortable. The first day is usually survivable because it is loud with logistics: paperwork, a nurse taking vitals, a bag being searched, a bed being assigned. Then the noise stops. Somewhere between day four and day ten, a very specific thought arrives, and it arrives with remarkable confidence: I have made my point. I feel better. I can do the rest of this from home.

Clinically, that moment is one of the most predictable and most dangerous points in a residential stay. It is also treatable, which is the part most people do not hear. If you or someone you love is sitting in that thought right now, you can talk it through with our admissions and clinical team at (877) 328-1968 before anyone signs a discharge form.

Why Day Six Can Feel Worse Than Day One

The urge to leave rarely peaks when withdrawal is at its worst. It peaks just after. There are a few reasons for that, and they stack.

The acute physical symptoms have started to lift. Sleep is still broken and appetite is still strange, but the shaking, sweating, and nausea have eased enough that the body no longer feels like an emergency. Feeling less terrible gets misread as being well.

At the same time, the emotional weather the substance was covering shows up on schedule: irritability out of proportion to anything happening, waves of shame about specific nights, and a flat, gray mood that is hard to explain to anyone who has not felt it. Post-acute symptoms like these are common and can fluctuate for weeks or months after the acute phase ends.

And the real world starts sending mail. A supervisor texts. A landlord calls. A child asks when you are coming home. Residential treatment protects a person from substances; it does not pause their life, and the weight of everything on hold becomes an argument for leaving that sounds responsible rather than avoidant.

What the Urge Actually Sounds Like

Counselors hear the same handful of sentences, and it is useful to recognize them as symptoms rather than conclusions:

The competence argument. I got through the hard part. I do not need to be watched anymore.
The comparison argument. These other people are much worse off than I am. I do not belong here.
The obligation argument. My family needs me. Staying here is selfish.
The grievance argument. The food, the schedule, my roommate, that one staff member. Something small becomes unbearable and portable.
The bargain. I will go to outpatient instead. I will call my sponsor every day. I will do it my way.

None of these are lies, exactly, which is what makes them persuasive. A good clinical response does not argue with the content; it slows the decision down long enough for the person to notice which part is the substance talking.

The Medical Reason Leaving Mid-Detox Is Not a Small Decision

This section matters more than any of the others, because some early departures are not just a setback in the treatment plan. They are a health risk.

Alcohol and benzodiazepine withdrawal can produce seizures and, in severe cases, delirium tremens. Both require medical supervision. If someone leaves partway through an alcohol or benzodiazepine taper, they lose the monitoring, the scheduled medication, and the ability of a nurse to catch escalating symptoms early. The risk window does not close simply because a person feels steadier on day five. Anyone withdrawing from alcohol or from benzodiazepines such as Xanax, Klonopin, Ativan, or Valium should complete that process under medical care, and should never stop those medications abruptly on their own. Our overview of residential treatment explains how medical monitoring is built into the daily structure.

Opioid risk works differently but is just as serious. Tolerance falls quickly during even a short period of abstinence, so a return to a previously routine dose after leaving treatment early can be fatal, particularly given how thoroughly fentanyl now contaminates the illicit supply. The Centers for Disease Control and Prevention and the National Institute on Drug Abuse both publish guidance on reduced tolerance and overdose prevention, including keeping naloxone on hand. If a loved one leaves treatment against clinical advice, naloxone in the house is not pessimism. It is a seatbelt.

Stimulant withdrawal is generally not medically dangerous in the same way, but the crash phase brings deep depression and, for some people, suicidal thinking. That is a reason for supervision too, just a different one. If someone is having thoughts of harming themselves, that is an urgent clinical matter, not something to sit with alone; in the United States, the 988 Suicide and Crisis Lifeline is reachable by call or text at any hour.

What a Program Should Do When Someone Says They Want to Go

Nobody is locked in. Residential treatment is voluntary, and a program that responds to the urge to leave with threats or shame has already lost the person. What effective programs do instead is fairly specific.

They separate the feeling from the paperwork. Most facilities ask for a defined waiting period, often 24 hours, between the statement and the signature. In practice, many of these urges soften overnight, especially once sleep improves.

They get a nurse involved before they get a debate involved. What looks like a motivational crisis is sometimes an undertreated symptom: pain, nausea, insomnia, or anxiety. Address the symptom and the exit plan often dissolves.

They use motivational rather than confrontational conversation. Instead of listing reasons to stay, a clinician asks what the person hoped this stay would accomplish and what they expect the first 48 hours at home to look like, hour by hour. That last question does more work than any lecture.

They document a real safety plan if the person still leaves. That means a naloxone kit where opioids are involved, written withdrawal warning signs, a scheduled outpatient or telehealth appointment within days rather than weeks, and a named person who will check in. Leaving early is not a reason to withhold care. Retention in treatment for an adequate length of time is one of the most consistently emphasized principles in NIDA’s research-based treatment guidance, and stepping down deliberately protects far more of the gains than walking out does. The American Society of Addiction Medicine similarly frames level of care as something to be adjusted based on assessed need rather than on how a person feels on a given afternoon.

What Families Can Do, and What Tends to Backfire

The phone call every family dreads is the one where their person sounds completely reasonable and wants a ride home. A few things help.

Do not negotiate the clinical question on the phone. You are not the treatment team, and being pushed into that role at 9 p.m. helps no one. Say that you love them, that you cannot make that call, and that you will join a family session with staff.

Do not agree to pick them up mid-conversation. Transportation is often the deciding variable, and slowing it down is not cruelty.

Ask for the treatment team. Signed releases exist for exactly this moment, and a counselor can usually convene a session quickly.

And say the specific thing that tends to land: I believe you that this is hard. I am asking for one more day. Families who want more structure for their own side of this can look at our addiction treatment programs and the family involvement built into them. SAMHSA also maintains free resources and a 24/7 national helpline at 1-800-662-HELP (4357) for families who need somewhere to think out loud.

If Someone Already Left

Leaving early is a common event, not a disqualifying one, and not a moral verdict. The useful response is fast, unembarrassed re-engagement: call the program back, say what happened, and ask what the next admission or step-down would look like. Nobody has to earn their way back in through a period of suffering first.

What should change is the plan, not the person. A second stay works best when it targets what actually drove the exit, whether that was untreated pain, an unaddressed co-occurring condition, a work or custody pressure nobody solved, or a family dynamic that made the phone a trapdoor.

Talking It Through Before You Decide

If the urge to leave is in the room right now, it is worth one conversation with someone who has watched many people move through this exact week. Our team provides residential detox and treatment in Northern California, and you can reach us at (877) 328-1968. You can also learn about our clinical team and editorial standards on our clinical leadership page.

Day six is not a verdict on whether you can recover. It is a known feature of the terrain, and it passes more often than it wins.

This article is for educational purposes only and is not a substitute for individualized medical or clinical advice, diagnosis, or treatment. Withdrawal from alcohol and benzodiazepines can be medically dangerous and should be managed under professional supervision. If you are experiencing a medical emergency, call 911. If you are having thoughts of suicide or self-harm, call or text 988 in the United States.

September 10, 2026/by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i

Returning to Residential Treatment After a Relapse: What the Second Stay Should Do Differently

Addiction, Blog, Treatment Resources

how a 5 day medical detox prepares you for residential rehab redwood forest path

Almost nobody walks back through the doors of a residential program feeling neutral about it. People come back quiet, or apologetic, or defensive, and a surprising number arrive convinced that returning proves treatment does not work for them. It does not. Return to substance use after a period of abstinence is a documented feature of chronic, relapsing conditions, and the National Institute on Drug Abuse describes substance use disorder in exactly those terms — a chronic brain condition with a relapse pattern comparable to other long-term medical conditions that require ongoing management.

What matters clinically is not whether someone returns, but whether the second stay is genuinely different from the first. A repeat admission that simply replays the original treatment plan tends to produce the original result. This article covers what a second residential episode should look like, the medical risks that make an unsupervised restart dangerous, and the questions worth asking any program before you commit to another admission. If you are trying to make this decision today, our admissions team can talk it through with you at 877-328-1968.

The First 48 Hours Back Are a Medical Question, Not a Motivational One

Before anything therapeutic happens, the immediate concern is physical safety, and this is where returning after a lapse carries risks that a first admission may not.

Tolerance falls quickly during abstinence. Someone who used opioids at a certain daily amount before treatment and then spent sixty days without them no longer has the tolerance that once made that amount survivable. Returning to a previously familiar dose after a period of abstinence is one of the highest-risk moments in the entire course of opioid use disorder, and the Centers for Disease Control and Prevention has long identified periods following abstinence as a window of elevated overdose risk. This is also why naloxone access and overdose education belong in every discharge plan, not just the ones for people who seem high risk.

Alcohol and benzodiazepines carry a different but equally serious danger. Withdrawal from either can produce seizures, and in the case of alcohol, delirium tremens — a medical emergency with real mortality. Repeated cycles of withdrawal are not benign; clinicians frequently observe that each subsequent withdrawal episode can be harder to manage than the last. Nobody should attempt to stop drinking or stop benzodiazepines on their own after a return to use. Withdrawal from these substances requires medical supervision, with monitoring, appropriate medication, and the ability to escalate care. That is not a preference. It is the standard of care, and it is the first reason a supervised residential treatment setting is safer than trying again at home.

What Actually Went Wrong Is Rarely What People Say Went Wrong

Ask someone in their first week back what happened and you will usually get a single event. A funeral. A layoff. A phone call from a family member. An argument that ended with car keys and a decision.

That event is real, but it is almost never the whole picture. Clinically, the useful work is reconstructing the two or three weeks before the day of use, because that is where the actual sequence lives. Someone stopped going to meetings in early March. Sleep degraded first. The evening routine that had structured recovery quietly dissolved when a work schedule changed. Contact with a sponsor thinned out, then stopped. Anxiety climbed and went untreated. By the time the funeral came, most of the protective structure had already eroded.

A strong second admission spends real time on that reconstruction, mapping the decision chain rather than the final decision. That map becomes the foundation of a different aftercare plan, because it identifies the specific point where the original plan stopped fitting the person’s actual life.

Five Things a Second Stay Should Do Differently

If a returning admission looks identical to the first one, something has been missed. Programs that take repeat episodes seriously typically revisit the following:

Reassess for co-occurring conditions. Untreated depression, anxiety, ADHD, bipolar disorder, or post-traumatic stress is one of the most common reasons an otherwise solid recovery plan fails. Symptoms are frequently obscured during active use and only become assessable after a period of stability — which means a person’s first stay may genuinely have been too early to see them clearly. The Substance Abuse and Mental Health Services Administration emphasizes integrated treatment for co-occurring disorders, meaning both conditions treated in the same program by the same team rather than sequentially or in separate places.

Revisit medication decisions. If someone declined buprenorphine, methadone, naltrexone, or acamprosate the first time, or started and stopped, that decision deserves a fresh, unhurried conversation. Preferences change with experience. Medication is not a lesser form of recovery, and the American Society of Addiction Medicine publishes clinical guidance supporting medication as a core component of care for opioid and alcohol use disorders.

Reconsider length of stay. Shorter stays are sometimes driven by work, childcare, or insurance rather than clinical need. If the first episode ended earlier than the team recommended, that is worth naming directly rather than repeating.

Change the discharge environment, not just the discharge plan. Returning to the same apartment, the same roommate, and the same commute with a new worksheet is a difficult setup. Sober living, a different city, a changed work arrangement — environmental change is often the variable with the most leverage.

Bring family in earlier. Families returning for a second episode carry their own exhaustion and, often, real anger. That deserves clinical attention in its own right, not a single session in the final week.

What Families Tend to Feel, and Why It Is Worth Saying Out Loud

Second admissions are harder on families than first ones. The hope is more guarded. People who emptied savings accounts, took leave from work, or rearranged their lives the first time often find themselves unable to summon the same optimism, and then feel guilty about that.

Naming this openly tends to help more than reassurance does. Family members do not need to feel hopeful in order to be useful; they need clear information, realistic expectations, and boundaries they can actually maintain. Programs that offer family education and separate family support — rather than only joint sessions focused on the person in treatment — generally serve returning families better. Our addiction treatment team works with families on exactly this, and you are welcome to call 877-328-1968 even if the person you are worried about has not agreed to anything yet.

Questions Worth Asking Before You Choose a Program Again

If the first program was not the right fit, the second choice deserves more scrutiny. Reasonable questions include: How do you assess and treat co-occurring mental health conditions, and who on staff is licensed to do that? What medications do you offer on site, and do you support continuing them after discharge? What does your continuing care actually consist of, and for how long? How do you involve family? What happens if I use again while enrolled — am I discharged, or is the plan adjusted?

That last question is diagnostic. A program that automatically discharges someone for a lapse is treating a symptom of the condition as a rule violation. Ask it directly, and listen to how quickly the answer comes.

A More Accurate Way to Read a Return

Time spent in recovery is not erased by a return to use. The skills, the relationships, the physical healing, and the self-knowledge from a first episode all remain, and most people find that the second time through, they engage faster and more honestly because they already know what the work feels like. That is not a consolation prize. It is a real clinical advantage, and it is one reason returning admissions often go better than people expect.

Our program in Northern California provides medically supervised detox and residential recovery care, including for people who have been in treatment before. If you or someone in your family is weighing a return, call 877-328-1968 to talk with our clinical team about what a different plan could look like.

If someone is showing signs of overdose, seizure, confusion, or severe withdrawal, call 911 immediately.

This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Withdrawal from alcohol, benzodiazepines, and other substances can be medically dangerous and should be managed under professional supervision. Please consult a qualified healthcare provider about your individual circumstances.

September 9, 2026/by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i

Alcohol Use Disorder After 60: Why Detox and Residential Care Look Different for Older Adults

Addiction, Alcohol, Blog

Alcohol addiction signs, dangerous withdrawal, FDA-approved medications, and evidence-based treatment from Bodhi. Reviewed by Jonathan Beazley, CADC-CAS. Joint Commission and CARF accredited programs.

Alcohol use disorder in later life is easy to miss and easy to explain away. A 68-year-old who has three drinks every evening has usually been doing some version of that for forty years, and the people around them have long since stopped counting. What changes is not the amount in the glass. What changes is the body receiving it, the medications competing with it, and the margin for error when someone finally stops. At Bodhi Addiction Treatment in Northern California, older adults are one of the groups whose withdrawal risk is most consistently underestimated, including by the person themselves. If you are weighing this for a parent, a spouse, or yourself, our admissions team can talk it through at (877) 328-1968.

Why the same three drinks hit harder at 65

Two things shift with age. Total body water declines, so the same volume of alcohol produces a higher blood alcohol concentration than it did at 40. And the liver metabolizes alcohol more slowly, so that concentration stays elevated longer. The practical result is that a drinking pattern which was stable for decades can start producing falls, confusion, and morning tremor without the person ever increasing their intake. The National Institute on Alcohol Abuse and Alcoholism maintains guidance specifically for older drinkers, and it reflects this: recommended limits for adults over 65 are lower than for younger adults, precisely because the same quantity is no longer the same exposure. Families often report that “nothing changed” — and they are right about the bottle. The change is physiological.

What families notice first, and mistake for aging

The presenting complaint is almost never “drinking.” It is a fall in the hallway at two in the morning. It is a missed doctor appointment, then three. It is a parent who has become vague on the phone in the evenings but sharp before noon — a pattern that is diagnostic if you know to look for it, and invisible if you do not. It is unexplained bruising, a new tremor in the hands at breakfast, weight loss, or a house that has quietly stopped being maintained. Adult children frequently arrive at intake having spent two years attributing all of this to dementia, depression, or simply getting older. Sometimes those conditions are genuinely present alongside the drinking. But time-of-day variability in cognition is one of the most useful distinctions available to a family, and it is worth mentioning to a physician directly.

Withdrawal after decades of drinking is a medical event, not a willpower test

This is the section that matters most. Alcohol withdrawal can cause seizures and delirium tremens, and both can be fatal. Older adults are at elevated risk. Decades of exposure, reduced physiologic reserve, and common comorbidities such as hypertension, atrial fibrillation, diabetes, and liver disease all raise the stakes of an unsupervised detox. An older adult who decides on a Sunday to simply stop should not do so at home. Neither should anyone withdrawing from benzodiazepines, which carry the same seizure risk and require a structured, gradual medical taper rather than abrupt cessation.

Medically managed withdrawal means vital signs monitored around the clock, symptom-triggered medication protocols, hydration and electrolyte correction, and thiamine — which matters enormously in this population, because thiamine deficiency in the setting of chronic alcohol use can produce a preventable and potentially permanent neurological injury. The American Society of Addiction Medicine publishes clinical criteria used across the field to match a person to the appropriate level of care, and age plus medical complexity is one of the reasons an older adult who “does not seem that bad” is often placed at a higher level than expected. Our residential treatment program is built around that supervised structure. If withdrawal has already started and symptoms are escalating — confusion, hallucinations, a racing heart, or any seizure activity — that is a 911 call, not a phone call to us.

The medication list is part of the clinical picture

Most people over 60 entering treatment arrive with a list: something for blood pressure, something for cholesterol, often something for sleep, sometimes an opioid for chronic pain, frequently a benzodiazepine prescribed years ago for anxiety and never revisited. Alcohol interacts with a great deal of that. Sedatives and opioids combined with alcohol compound respiratory depression. Acetaminophen and alcohol together stress the liver. Several common medications simply become unpredictable in the presence of daily drinking.

Part of what residential care does for an older adult is create the first opportunity in years for someone to look at the entire list at once, with the drinking finally accounted for honestly. That review is done with the prescribing physicians, not around them. It routinely produces changes that would have been unsafe to attempt at home.

What the first week actually looks like

Day one and two are the hardest and the most closely watched. Expect frequent vitals, poor sleep, a shaky appetite, and staff checking in more often than feels necessary — that frequency is the point. Days three through five, the acute physical symptoms usually begin to settle and something else surfaces: older adults very often become tearful, and it takes them by surprise. Forty years of feeling managed by a nightly routine ends, and grief that the drinking was holding at arm’s length arrives all at once.

By the end of week one, most people are sleeping in fragments rather than not at all, eating something at every meal, and beginning to participate in group. A common and specific worry in this age group is being the oldest person in the room. In practice, older adults tend to be received in group with unusual respect, and the mixed-age setting is frequently reported afterward as one of the more valuable parts of the stay. Concurrent mental health treatment begins in this window as well, since depression and anxiety are highly prevalent here and rarely resolve on their own once the alcohol is gone.

What is actually driving it

Late-onset drinking — a pattern that begins or sharply worsens after 55 — often traces to identifiable losses: the death of a spouse, retirement removing both structure and identity, chronic pain, a shrinking social circle, or a move away from a longtime home. The Substance Abuse and Mental Health Services Administration has published extensively on treatment approaches for older adults, and a consistent theme is that isolation is not a side note in this population; it is a primary driver and a primary relapse risk. A plan that addresses the drinking but leaves someone returning to an empty house with nothing on the calendar is an incomplete plan.

Thinking and memory: what tends to come back

Cognitive improvement after sustained abstinence is real, and for many older adults it is the most motivating thing they experience. Attention, processing speed, and short-term recall commonly improve over weeks to months. It is not universal and it is not total — some alcohol-related cognitive impairment persists, and where dementia is independently present, sobriety will not reverse it. Anyone promising a specific recovery percentage is guessing. What can be said honestly is that the ceiling is usually higher than families expect, and that it is not reachable while drinking continues. For a broader overview of the care available, see our addiction treatment page.

Starting the conversation

Shame is the largest obstacle in this age group. Many older adults grew up with a moral framing of alcohol problems and hear any concern as an accusation of failure at the end of an otherwise decent life. Confrontation reliably backfires. What tends to work is specific, non-judgmental observation — naming the fall, the missed appointment, the tremor — paired with a concrete next step someone else has already arranged. Person-first language matters here more than anywhere: this is a person with alcohol use disorder, a treatable medical condition, and framing it that way is often the difference between a conversation and a closed door. When you are ready to talk about placement, insurance, or what a medically supervised admission would involve, reach our team at (877) 328-1968.

Educational disclaimer

This article is for general educational purposes only and is not medical advice, diagnosis, or treatment. It does not replace consultation with a qualified physician or licensed clinician who knows the individual’s history. Do not start, stop, or change any medication based on this content. Never attempt to withdraw from alcohol or benzodiazepines without medical supervision. If you are experiencing a medical emergency, call 911.

Sources and further reading: National Institute on Alcohol Abuse and Alcoholism (NIAAA), Substance Abuse and Mental Health Services Administration (SAMHSA), American Society of Addiction Medicine (ASAM), Centers for Disease Control and Prevention (CDC).

September 9, 2026/by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i

Prescription Stimulant Use Disorder: When Adderall or Vyvanse Use Needs Residential Care

Addiction, Blog, Prescription Drugs

Most people who develop a problem with prescription stimulants did not set out looking for a high. They started with a prescription that worked, or a roommate’s Adderall during finals week, or a job that seemed to demand more hours than a human body has. The progression is gradual enough that it is genuinely hard to see from the inside, and that is part of why prescription stimulant use disorder tends to arrive at our door later than it should.

What Prescription Stimulant Use Disorder Actually Looks Like

The prescription stimulants involved are usually amphetamine-based (Adderall, Vyvanse, Dexedrine) or methylphenidate-based (Ritalin, Concerta). What changes over time is rarely the drug and almost always the relationship to it.

In clinical intakes, the pattern people describe is remarkably consistent. The dose that used to carry an eight-hour workday stops carrying it. A second dose gets added in the afternoon, then a third in the evening, and the prescription that was written for thirty days runs out on day nineteen. That shortfall creates its own problem: a week of forced abstinence at the end of every month, which people experience as a crash so unpleasant that avoiding it becomes a motive of its own.

Route of use often shifts too. Crushing and insufflating tablets, or moving to intravenous use, changes both the pharmacology and the medical risk profile considerably. When someone discloses that during an assessment, it moves the conversation immediately toward medical evaluation rather than counseling alone.

The Line Between a Prescription and a Problem

Families and clients both ask where the line is. There is no single blood test or score that settles it, but clinicians look at a recognizable cluster: taking more than prescribed, running out early, obtaining pills from sources other than the prescriber, using to perform rather than to function, unsuccessful attempts to cut back, and continuing despite clear harm to sleep, weight, relationships, or cardiac health.

The National Institute on Drug Abuse maintains accessible overviews of prescription stimulant misuse and its health consequences, and it is a reasonable starting point for anyone trying to understand the difference between therapeutic use and a use disorder. See NIDA for that background.

One detail worth naming: having a legitimate diagnosis does not protect someone from developing a use disorder, and having a use disorder does not mean the original diagnosis was fake. Both can be true at once, and treating them as mutually exclusive is one of the more common ways people get stuck.

Prescription Stimulants Are Rarely the Only Substance Involved

By the time someone reaches residential care, stimulants are usually not the whole picture. Sleep becomes impossible on a high stimulant load, so people reach for something to come down: alcohol most often, sometimes benzodiazepines, sometimes cannabis. That secondary use is not a side note. It changes what a safe withdrawal looks like.

This is the point where self-managed detox becomes dangerous. Stopping stimulants abruptly is physically uncomfortable but not typically life-threatening. Stopping alcohol or benzodiazepines abruptly is a different matter: both carry a real risk of seizures and, in the case of alcohol, delirium tremens. Anyone who has been drinking heavily or taking benzodiazepines daily needs medically supervised withdrawal, not willpower and a quiet weekend. If that describes your situation or your family member’s, please call us at (877) 328-1968 before making any changes on your own.

A thorough intake also screens cardiovascular status. Sustained high-dose stimulant use is associated with hypertension, tachycardia, and in some cases cardiac complications, which is one reason a medical assessment belongs at the front of the process rather than somewhere in week two.

What the First Week Actually Feels Like

People arriving off prescription stimulants often expect the first week to be dramatic. Usually it is the opposite, and that surprises them.

The dominant experience is flatness. Sleep tends to come first and come hard, sometimes twelve or fourteen hours at a stretch for the first two or three days, and it can then flip into fragmented insomnia. Appetite returns, sometimes forcefully. Concentration is poor. Most notably, the world stops being interesting: anhedonia is the symptom clients name most often, and it is the one most likely to make someone want to leave.

Low mood in this window deserves genuine clinical attention rather than reassurance. Depressive symptoms during stimulant withdrawal can be significant, and passive suicidal thinking is not rare, which is why monitoring is built into residential care rather than left to chance. It also usually lifts. Telling someone on day four that their brain will feel like theirs again is a claim we can make honestly, provided we are also honest that the timeline is measured in weeks rather than days and varies by person.

Treating the ADHD Question Honestly

This is the conversation people are most anxious about: if the stimulant was treating something real, what happens now?

The clinically defensible answer is that the question cannot be answered accurately while someone is actively misusing. Attention, mood, and executive function all look impaired during withdrawal regardless of whether an underlying attention disorder exists. Reassessment generally waits for a period of stability, and it belongs to a prescriber who has the full history.

Non-stimulant options exist, and behavioral strategies for attention and organization work whether or not medication is part of the eventual plan. Any specific medication decision is between a client and their prescriber. The National Institute of Mental Health publishes plain-language material on ADHD and co-occurring conditions that families often find useful while they wait for that reassessment. Where a co-occurring diagnosis is confirmed, integrated mental health treatment runs alongside substance use care rather than after it.

What Families Tend to Notice First

Families rarely report the pills. They report the pattern around them: weight loss they cannot explain, a person who is up at three in the morning reorganizing a closet, irritability that has replaced a personality, a monthly cycle of a few flat exhausted days that everyone has learned to work around. Dental problems and skin picking show up too.

If you are the family member reading this, the most useful thing you can bring to an assessment is specific observation rather than diagnosis. Dates, amounts if you know them, and what changed. That detail shapes a treatment plan far more than a label does.

The Clinical Work After Stabilization

There is currently no medication approved to treat stimulant use disorder the way buprenorphine or naltrexone are used for opioid use disorder. Treatment is therefore behavioral, and the behavioral approaches with the strongest research support are structured rather than improvised: contingency management, cognitive behavioral therapy, and structured stimulant-specific programming.

In a residential treatment setting, that work is paired with the practical things that make early recovery survivable: a sleep schedule that is actually enforced, meals, exercise, and a daily structure that does not depend on chemical energy. Clients who have organized their working lives around stimulants often find the schedule itself is the intervention.

The Substance Abuse and Mental Health Services Administration publishes guidance on levels of care and on evidence-based practices for stimulant use, and its treatment locator is a useful reference for comparing options in your area.

When Residential Care Is the Right Level

Residential care is not the answer for every person misusing prescription stimulants. It becomes the appropriate level when outpatient attempts have not held, when there is concurrent alcohol or benzodiazepine dependence requiring supervised withdrawal, when psychiatric symptoms need daily monitoring, when there is stimulant-induced psychosis, or when the home environment makes abstinence unrealistic.

Our admissions team can talk through which level of care fits and what your coverage looks like. You can reach us at (877) 328-1968 or start with our insurance verification page. Ask about medical detox capability, whether psychiatric care is on site, and how the program handles ADHD reassessment. Those three answers tell you a great deal about whether a program is equipped for this specific problem.

A Note on What Recovery Looks Like Here

The people who do well are usually not the ones who arrive convinced. They are the ones who stay past the flat week. Cognitive clarity and motivation return unevenly, and expecting a straight line sets people up to read a hard Thursday as failure. It is more accurate, and more useful, to expect gradual and uneven improvement over the first several weeks.

If you are somewhere in the middle of this, whether it is your own use or someone you love, the decision in front of you is not a lifelong commitment. It is one assessment.

Educational Disclaimer

This article is for general educational purposes and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified healthcare professional, and no outcome is guaranteed. Do not stop or change any prescribed medication without speaking to your prescriber. Withdrawal from alcohol and benzodiazepines can be medically dangerous and requires supervision. If you are experiencing a medical emergency, call 911. If you are having thoughts of suicide, call or text 988 to reach the Suicide and Crisis Lifeline.

September 8, 2026/by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i

Medications for Opioid Use Disorder in Residential Treatment: Buprenorphine, Naltrexone, and What to Expect

Addiction, Blog, Prescription Drugs, Treatment Resources

San Francisco Bay Area addiction treatment consulting and program placement | Bodhi nationwide network

Most people who come to residential treatment for opioid use disorder have already tried to stop on their own, often many times. They know the arc by heart: a rough first night, two days of bone aches and cold sweats, then a third day when the only thought still functioning is the one about relief. The return to use that follows rarely feels like a decision.

What many people have never been told is that medication can change the shape of that arc, and that starting it under medical supervision inside a structured program is nothing like trying to manage it alone. Medications for opioid use disorder, sometimes shortened to MOUD or MAT, come up in nearly every admissions call we take, and they remain among the most misunderstood parts of addiction care.

What MOUD Is, and What It Is Not

Three medications are approved in the United States for opioid use disorder: buprenorphine (often dispensed in combination with naloxone), naltrexone, and methadone. They work in very different ways. Buprenorphine and methadone occupy the same receptors that opioids do, which quiets withdrawal and craving without producing the same intensity of effect. Naltrexone does the opposite, blocking those receptors so that opioids produce little or nothing.

Both the National Institute on Drug Abuse and the Substance Abuse and Mental Health Services Administration describe these medications as evidence-based treatment for opioid use disorder, not as a lesser alternative to abstinence-based care. That framing matters, because the objection we hear most often is some version of trading one addiction for another. The concern deserves a real answer rather than a dismissal. Physical dependence and addiction are not the same thing. A prescribed, stable dose that does not produce intoxication, does not escalate, and does not organize a person’s whole day around obtaining it looks nothing like the pattern that brought them to treatment. Many people describe the difference simply: the noise stops.

The First Week on Buprenorphine

The most counterintuitive part of starting buprenorphine is that a person needs to be in withdrawal before the first dose. Because buprenorphine binds tightly to opioid receptors, taking it while other opioids are still present can displace them abruptly and set off precipitated withdrawal, which is worse than what the person walked in with. So clinical staff wait, and they measure. Withdrawal is scored on a structured scale, and the specific signs matter: gooseflesh on the forearms, pupils widening, yawning that will not stop, restless legs that make sitting through a group impossible.

When the timing is right, the first dose often works quickly. People frequently describe something settling within half an hour to an hour, and the description tends to be understated rather than dramatic. The aches back off. The sweating stops. Someone who could not sit still for ten minutes eats a full meal that afternoon.

The following days are less about relief and more about calibration. Doses are adjusted, sometimes several times, until cravings are quiet and the person is not sedated. Constipation is common and gets treated. Sleep is usually the last thing to come back, and it may take weeks rather than days. This is one reason a residential setting helps: adjustments happen with a nurse in the building rather than at an appointment two weeks out. Potent fentanyl analogs in the drug supply have also made induction less predictable, and some people need a longer waiting window or a modified approach. That is a clinical judgment call, not something to attempt at home.

Naltrexone: A Longer Runway, a Different Decision

Naltrexone appeals to people who want no opioid in their system at all, and for some it is the right fit. The obstacle is the gap it requires. Because naltrexone blocks receptors, it cannot be started until a person has been off opioids long enough to clear them, commonly a week or more depending on what was used, and starting too early can trigger significant withdrawal. Very few people can hold that gap open by themselves. A residential stay is often what makes it possible at all.

Naltrexone does not relieve withdrawal, so the days before the first dose are managed with supportive medications for nausea, muscle aches, anxiety, and sleep. Once it is in place, usually as a monthly extended-release injection, people tend to report that cravings are quieter and less interesting. The thought still arrives; it just has less pull. Liver function is monitored, and anyone with significant pain problems needs a plan in advance, since standard opioid pain control will not work normally while the medication is active.

Methadone, and Why Access Looks Different

Methadone remains an effective option, particularly for people with long histories of high-dose use, but it is dispensed through federally regulated opioid treatment programs rather than prescribed like other medications. In practice that means coordination: a residential program works with a licensed opioid treatment program for dosing, and the discharge plan has to include a receiving clinic before the person leaves. When someone arrives already stable on methadone, the goal is continuity. Stopping an established dose because a person changed levels of care is a preventable setback.

Sorting out which option fits your situation, or a family member’s, is a conversation worth having with clinicians rather than the internet. You can reach our admissions team at (877) 328-1968.

What Families Notice in the First Month

Families often expect medication to produce a visible transformation and are unsettled when week one sounds flat instead. Phone calls are short. The person sounds tired, sometimes irritable, not especially grateful. That is usually what stabilization looks like from the outside, not a sign of failure. Affect returns in the second and third weeks, in small ways: a joke on the phone, a question about someone else’s life, an actual opinion about dinner.

The other thing families raise is the fear that medication is a loophole, a way to feel better without changing anything. The honest answer is that medication makes change possible without guaranteeing it. It reduces the physiological pressure that makes therapy, accountability, and rebuilt routines nearly impossible to sustain. It does not do those things on its own, and no clinician should promise that it will.

Medication Is One Part of the Day, Not the Whole Plan

Inside residential treatment, the medication visit is a small part of the schedule. The rest is individual therapy, process groups, relapse-prevention skills, work on trauma when a person is stable enough for it, family sessions, and case management aimed at the practical wreckage: employment, housing, court dates, custody. The American Society of Addiction Medicine frames medication as one component within a level of care matched to a person’s overall needs, and that is roughly how it feels from the inside. Medication makes the day workable. The day is where the change happens.

Length of stay is matched to the person rather than a fixed template, and most plans step down rather than stop. An outpatient program with continued medication management is a far more durable ending than a discharge date and a phone number.

Safety Issues Worth Saying Plainly

Three points deserve emphasis. First, tolerance drops fast during any period away from opioids, which means that a return to a previously familiar amount can be fatal. Anyone leaving treatment, and their family, should have naloxone on hand and know how to use it. This is not a statement of expectation; it is basic preparation.

Second, opioid use rarely travels alone. Many people are also using alcohol, benzodiazepines, or both. Withdrawal from alcohol and from benzodiazepines can cause seizures and delirium and can be life-threatening, unlike opioid withdrawal, which is agonizing but not usually dangerous in itself. Those withdrawals require medical supervision and a structured taper. Nobody should attempt them alone or on a self-designed schedule, and a program needs to know about every substance involved before detox begins.

Third, stimulant use alongside opioids is increasingly common, and there is no approved medication for stimulant use disorder, so that side of the plan relies on behavioral treatment. Say what you are actually using at intake. Accurate information is what makes a safe plan possible.

Where to Start

There is no single correct medication. The decision is a shared one, shaped by history, other medical conditions, pain, prior attempts, and what a person is willing to sustain. It also does not need to be settled before anyone asks for help. Most people work it out in the first days of care, with a physician in the room.

If cost is what is holding you back, you can verify your insurance benefits before committing to anything, or call (877) 328-1968 and ask. It is a short conversation and it costs nothing.

This article is for educational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. Decisions about medications for opioid use disorder should be made with a qualified healthcare professional who knows your history. Withdrawal from alcohol or benzodiazepines can be medically dangerous and requires supervision. If you are experiencing a medical emergency, call 911.

September 8, 2026/by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i

Continuing Care After Residential Treatment: Building a Plan That Holds

Blog, Treatment Resources

Sunlight filtering through tall redwood trees on a quiet forest path

Discharge day at a residential program rarely feels the way people imagine it will. Most expect relief. What many describe instead is a flat, unsteady feeling: the meals, the med window, the 9 a.m. group, the person down the hall who noticed when you went quiet, all of it ends at once. Thirty days of scaffolding comes down in an afternoon. Whether the weeks that follow hold together usually has less to do with willpower than with how carefully the plan was built while the scaffolding was still up.

Why the Weeks Right After Residential Care Carry So Much Weight

Clinically, the period right after residential treatment is understood as a high-vulnerability window. Federal health agencies consistently frame substance use disorder as a chronic, relapse-prone condition that responds to sustained care rather than a single episode of treatment; the National Institute on Drug Abuse discusses this in its treatment principles materials (nida.nih.gov). The practical translation is unglamorous. A completed residential stay is a beginning that has been stabilized, not a problem that has been closed.

Several things converge. Sleep is often still unreliable. Mood can swing without an obvious trigger. Cravings tend to arrive attached to specific cues rather than as constant background noise, which makes them easy to underestimate on a good week. And the environment changes completely: the same kitchen, the same commute, the same group chat, the same unresolved conversation with a family member. None of that was in the room during treatment.

What Discharge Planning Actually Looks Like Inside a Program

Good continuing care planning does not happen in the last two days. In well-run programs it starts in the first week and is revised repeatedly. By the midpoint of a stay, a clinical team should be able to answer concrete questions: what level of care comes next, on what date, at what address, with whose name on the intake, and what happens if that placement falls through.

A plan worth the paper it is printed on specifies the next level of care with a start date, ideally within days of discharge rather than weeks; a named prescriber and a plan for any medications, including refills before the first appointment; a housing decision that has been examined honestly rather than assumed; a therapist or counselor for individual work; identified peer or mutual-aid support with actual meeting times; and a written response plan for a return to use, including who gets called first.

That last item is the one people resist. Writing down what happens if you use again can feel like planning to fail. In practice it is closer to a fire drill. Decisions made in advance, while thinking clearly, are far better than decisions made at 11 p.m. in a moment of shame.

The Step-Down Question: PHP, IOP, or Straight Home

The most consequential choice at discharge is usually the level of care that follows. Stepping directly from twenty-four-hour support to a single weekly therapy appointment is a large drop, and for many it is too large. Structured step-down options exist precisely to shorten that fall.

A partial hospitalization program typically involves clinical programming most of the day, most days of the week, while the person sleeps elsewhere. It suits people still medically or psychiatrically fragile, or who need daily contact to keep footing. Intensive outpatient care is lighter, often several sessions per week in the evening, which makes it workable alongside a job or school. Some people move through both in sequence after a residential stay.

Two questions tend to clarify the decision better than any assessment score. First: is the living environment stable and reasonably free of substances? Second: is there a co-occurring mental health condition that is still being adjusted? A yes to the second, or a no to the first, generally argues for the higher level of care, whatever the calendar says.

Medication Decisions Do Not End at Discharge

For opioid use disorder, medication is a mainstream, evidence-supported component of treatment, and the Substance Abuse and Mental Health Services Administration maintains extensive guidance and a treatment locator for programs that provide it (samhsa.gov). Medications also exist to support alcohol use disorder. Whether any of them is appropriate is a conversation for a prescriber who knows the full history; nothing in an article can substitute for that.

What continuing care planning can do is remove the logistical failure points. A prescription that runs out four days before the first outpatient appointment is a preventable and common crisis. So is arriving at a new provider who has no records. Asking the residential team to confirm the handoff in writing, and to send documentation ahead, is a reasonable request.

A safety point belongs here: withdrawal from alcohol and from benzodiazepines can involve seizures and other serious medical complications, and either requires medical supervision rather than an independent attempt to stop or taper. If someone leaves treatment still taking a prescribed benzodiazepine, any change to that medication needs to run through a physician. Abrupt discontinuation is genuinely dangerous.

Tolerance Has Changed, and That Changes the Risk

This section matters more than any other. After a period of abstinence, tolerance to opioids drops substantially. A quantity that felt routine before treatment can be life-threatening afterward. The Centers for Disease Control and Prevention publishes public education material on overdose risk and on naloxone, the medication that can reverse an opioid overdose (cdc.gov).

Naloxone should leave treatment with the person, or be obtained in the first week, and someone in the household should know where it is and how to use it. It is the same logic as a smoke detector. Discussing it openly also does something useful in a family: it establishes that a return to use is a medical event to respond to, not a verdict on anyone’s character.

Building the Week Before You Need It

Residential treatment supplies structure by default. At home, structure has to be constructed on purpose, and the useful version is specific. Not a resolution to exercise, but a walk at 7 a.m. Not an intention to attend meetings, but the Tuesday 7 p.m. meeting on a particular street. Not an idea about sleep, but a fixed wake time held even on the mornings it feels pointless.

The first two weeks are also where people overcommit. Returning to a full workload, repairing every strained relationship, and catching up on months of obligations in the same fortnight is a recipe for exhaustion. Case managers often push for the opposite, deliberately underscheduling the early weeks so appointments and sleep are protected. Case management support is sometimes what keeps a plan intact through the practical friction of insurance calls, transportation, and paperwork.

What Families Tend to Notice

Family members frequently describe the same sequence. A quiet, slightly withdrawn first week. Irritability in the second, often over something small. Then, somewhere in the third or fourth week, a recognizable version of the person they remember, alongside continued unevenness. Knowing this is common makes it less frightening.

What helps: consistency instead of surveillance, direct questions asked calmly, and separate support for the family, since living with someone in early recovery is its own strain. What does not: monitoring every mood as evidence, or treating discharge as the moment everything gets discussed at once. Some conversations are better held with a clinician in the room.

When the Plan Needs to Change

A continuing care plan is a working document. Signs that it needs revision include missed appointments becoming a pattern, sleep collapsing again, isolation, resumed contact with people connected to prior use, or a return to use of any substance. None of these mean treatment failed. They mean the current level of support is not matching the current need, which is useful information.

Returning to a higher level of care is a clinical adjustment, not a punishment, and the sooner it happens the smaller it needs to be.

Talking It Through

If you are approaching discharge, or supporting someone who is, and the plan for the next ninety days is still vague, that is worth a phone call. Our team can talk through step-down options, medication continuity, and placement within a vetted network of Northern California programs. Reach us at (877) 328-1968 to discuss what a realistic continuing care plan looks like in your situation, including insurance and timing.

Nothing about this requires having it figured out first. Most of the useful planning happens in conversation. Call (877) 328-1968 when you are ready to start.

This article is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment, and it does not establish a clinician-patient relationship. Withdrawal from alcohol and benzodiazepines can be medically dangerous and requires professional supervision. Decisions about medications, tapering, and level of care should be made with a qualified healthcare provider who knows your history. If you are experiencing a medical emergency, call 911. If you or someone you know is in crisis, the 988 Suicide and Crisis Lifeline is available by calling or texting 988 in the United States.

September 7, 2026/by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i